As of April 19, 2025, Gossamer Bio (GOSS) has a market cap of $0.19 billion USD. According to our data, Gossamer Bio is ranked No.7031 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $0.19 B |
-6.65%
|
Dec 31, 2024 | $0.21 B |
-0.88%
|
Dec 29, 2023 | $0.21 B |
-57.93%
|
Dec 30, 2022 | $0.49 B |
-80.81%
|
Dec 31, 2021 | $2.56 B |
16.96%
|
Dec 31, 2020 | $2.19 B |
-38.13%
|
Dec 31, 2019 | $3.54 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Blueprint Medicines
BPMC
|
$5.41 B |
0.000 M
|
![]() USA
|
![]() Iovance Biotherapeutics
IOVA
|
$1.00 B |
-0.000 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.80 B |
-0.000 M
|
![]() Canada
|
![]() Deciphera Pharmaceuticals
DCPH
|
$2.21 B |
2.213 B
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
-0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Relay Therapeutics
RLAY
|
$0.46 B |
-0.000 M
|
![]() USA
|
![]() Revolution Medicines
RVMD
|
$6.83 B |
-0.000 M
|
![]() USA
|
![]() Arcus Biosciences
RCUS
|
$0.83 B |
-0.000 M
|
![]() USA
|
![]() Nektar Therapeutics
NKTR
|
$0.12 B |
-0.670 M
|
![]() USA
|
Market Cap | = | GOSS Stock Price | * | GOSS Shares Outstanding |
= | $0.84 | * | 0.23 B | |
= | $0.19 B |